Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...

announced today the successful completion of randomization in the , with the total number of patients randomized exceeding the upper goal set for the Study. The DAPT Study is a four-year clinical ...

Of 241 survey participants who self-reported a post-vaccination syndrome, the five most common symptoms were exercise intolerance (71%), excessive fatigue (69%), numbness (63%), brain fog (63%), and ...

Peer review and the editorial process yield frequent improvements in research abstracts of randomized clinical trial (RCT) ...

Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 study titled A Phase 3 ...

Genetically decreased vitamin D levels are unlikely to have a large effect on risk of type 1 diabetes, according to results of a Mendelian randomization study published in PLOS Medicine.